Topotecan Completed Phase 1 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00287963Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00322751Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
NCT00002537Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer